बेल्जियम - फ़्रेंच - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - lisinopril dihydraté 21,78 mg - eq. lisinopril 20 mg; hydrochlorothiazide 12,5 mg - comprimé - 20 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; lisinopril dihydraté 21.78 mg - lisinopril and diuretics

बेल्जियम - फ़्रेंच - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - lisinopril dihydraté 21,78 mg - eq. lisinopril 20 mg; hydrochlorothiazide 12,5 mg - comprimé - 20 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; lisinopril dihydraté 21.78 mg - lisinopril and diuretics

बेल्जियम - फ़्रेंच - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - lisinopril dihydraté 21,78 mg - eq. lisinopril 20 mg; hydrochlorothiazide 12,5 mg - comprimé - 20 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; lisinopril dihydraté 21.78 mg - lisinopril and diuretics

बेल्जियम - फ़्रेंच - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - lisinopril dihydraté 10,89 mg - eq. lisinopril 10 mg; hydrochlorothiazide 12,5 mg - comprimé - 10 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; lisinopril dihydraté 10.89 mg - lisinopril and diuretics

बेल्जियम - फ़्रेंच - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - lisinopril dihydraté 21,78 mg - eq. lisinopril 20 mg; hydrochlorothiazide 12,5 mg - comprimé - 20 mg - 12,5 mg - hydrochlorothiazide 12.5 mg; lisinopril dihydraté 21.78 mg - lisinopril and diuretics

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - lisinopril 10 mg - lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a vari

पुर्तगाल - पुर्तगाली - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

faes farma portugal, s.a. - lisinopril + hidroclorotiazida - comprimido - 20 mg + 12.5 mg - lisinopril, di-hidratado 21.78 mg ; hidroclorotiazida 12.5 mg - lisinopril and diuretics - genérico - duração do tratamento: longa duração

पुर्तगाल - पुर्तगाली - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

faes farma portugal, s.a. - lisinopril + hidroclorotiazida - comprimido - 20 mg + 12.5 mg - lisinopril, di-hidratado 21.78 mg ; hidroclorotiazida 12.5 mg - lisinopril and diuretics - genérico - duração do tratamento: longa duração

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

safecor health, llc - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) - lisinopril 10 mg - lisinopril tablets usp are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a vari

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

major pharmaceuticals - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) - lisinopril 5 mg - lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety